Novozymes Biopharma DK A/S — Credit Rating and Financial Key Figures
CVR number: 29603537
Krogshøjvej 36, 2880 Bagsværd
tel: 44460000
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Other operating income | 47 429.01 | 58 801.63 | 242.70 | 977.42 | 12 812.48 |
| External services | - 234.77 | -81.20 | - 156.50 | -65.65 | -41.30 |
| Gross profit | 47 194.25 | 58 720.43 | - 399.20 | 911.76 | 12 771.17 |
| EBIT | 47 194.25 | 58 720.43 | - 399.20 | 911.76 | 12 771.17 |
| Other financial income | 4 693.83 | 4 503.08 | 2 159.76 | 18 513.26 | 2 033.73 |
| Other financial expenses | -1 035.15 | -4 422.30 | -3 453.64 | - 312.57 | -6.17 |
| Income from other inv. held as non-curr. assets | 1 769.48 | 6 210.40 | 267 421.22 | ||
| Pre-tax profit | 52 622.41 | 65 011.62 | 265 728.14 | 19 112.45 | 14 798.73 |
| Income taxes | -11 460.15 | -13 892.67 | 338.16 | -4 204.74 | -3 255.72 |
| Net earnings | 41 162.27 | 51 118.95 | 266 066.30 | 14 907.71 | 11 543.01 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current loans receivable | 175.80 | 175.80 | |||
| Long term receivables total | 175.80 | 175.80 | |||
| Inventories total | |||||
| Current amounts owed by group member comp. | 166 234.14 | 122 260.33 | 321 861.97 | 75 316.73 | 27 789.58 |
| Current other receivables | 42.15 | 0.01 | |||
| Current deferred tax assets | 672.59 | 295.44 | 633.60 | 53.41 | 30.21 |
| Short term receivables total | 166 906.73 | 122 555.78 | 322 495.57 | 75 412.29 | 27 819.80 |
| Cash and bank deposits | 429.35 | 464.49 | 500.51 | 507.50 | 1 609.73 |
| Cash and cash equivalents | 429.35 | 464.49 | 500.51 | 507.50 | 1 609.73 |
| Balance sheet total (assets) | 167 511.89 | 123 196.07 | 322 996.09 | 75 919.79 | 29 429.53 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 612.00 | 612.00 | 612.00 | 612.00 | 612.00 |
| Shares repurchased | 40 000.00 | 53 000.00 | 265 000.00 | 60 000.00 | 7 000.00 |
| Retained earnings | 15 579.95 | 3 742.22 | - 210 138.83 | -4 072.53 | 3 835.18 |
| Profit of the financial year | 41 162.27 | 51 118.95 | 266 066.30 | 14 907.71 | 11 543.01 |
| Shareholders equity total | 97 354.22 | 108 473.16 | 321 539.47 | 71 447.18 | 22 990.19 |
| Provisions | 56 699.14 | ||||
| Non-current liabilities total | |||||
| Current trade creditors | 62.50 | 62.56 | 77.50 | ||
| Current owed to group member | 148.44 | 121.88 | 133.14 | ||
| Short-term deferred tax liabilities | 9 915.95 | 13 515.52 | 4 043.37 | 3 232.52 | |
| Other non-interest bearing current liabilities | 3 331.64 | 1 144.83 | 1 334.74 | 218.60 | 3 206.82 |
| Current liabilities total | 13 458.53 | 14 722.91 | 1 456.62 | 4 472.61 | 6 439.34 |
| Balance sheet total (liabilities) | 167 511.89 | 123 196.07 | 322 996.09 | 75 919.79 | 29 429.53 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.